Your Partner for Growth, Hybridan

Hybridan

Your Partner for Growth

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Equity Bottom-Up

<ul>
<li>Aptamer Group 0.95p £25.62m (APTA.L) The developer of next-generation synthetic binders for the life sciences industry reports a new TrueAmp Library Preparation Kit is using Aptamer's proprietary Optimer binders.</li>
<li>These are being used as an enabling technology for stability at room temperature, the specialised TrueAmp polymerase maximises coverage across typically hard-to-sequence regions of the genome - while maintaining high accuracy during DNA copying.</li>
<li>This product launch demonstrates the real-world value of the Optimer technology in enabling market-ready products.</li>
</ul>


Aptamer Group 0.95p £25.62m (APTA.L) The developer of next-generation synthetic binders for the life sciences industry reports a new TrueAmp Library Preparation Kit is using Aptamer's proprietary Optimer binders.
These are being used as an enabling technology for stability at room temperature, the specialised TrueAmp polymerase maximises coverage across typically hard-to-sequence regions of the genome - while maintaining high accuracy during DNA copying.
This product launch demonstrates the real-world value of the Optimer technology in enabling market-ready products.


Hybridan Small Cap Feast: 11 February 2026

Cross Asset Strategy

<ul>
<li>In the latest bid to revitalise the UK’s IPO pipeline, the Government has reaffirmed its commitment to the creation of an 'an innovative new stock market' coined the Private Intermittent Securities and Capital Exchange System or PISCES for short.</li>
<li>PISCES plans to operate as a regulated platform for the intermittent trading of private company shares.</li>
<li>It will kick off with a five-year stint in the “FCA sandbox” which allows the Government to modify the platform or disapply certain parts of the legislative framework based on market feedback.</li>
</ul>


In the latest bid to revitalise the UK’s IPO pipeline, the Government has reaffirmed its commitment to the creation of an 'an innovative new stock market' coined the Private Intermittent Securities and Capital Exchange System or PISCES for short.
PISCES plans to operate as a regulated platform for the intermittent trading of private company shares.
It will kick off with a five-year stint in the “FCA sandbox” which allows the Government to modify the platform or disapply certain parts of the legislative framework based on market feedback.


PISCES – Shooting the Lights Out or Shooting Ourselves in the Foot?

Strategic Minerals PLC / Equity Bottom-Up

<ul>
<li>The minerals exploration and development Company reports that its proposed joint venture partner, GreenTech Metals Limited, has announced that the Phase 1 drill programme will be accelerated with the addition of a second drill rig at the Munni Munni Platinum-PalladiumCopper-Nickel Project.</li>
<li>GreenTech and Alien are progressing the final administrative processes to enable conclusion of the transaction, and a further announcement will be made in due course.</li>
<li>The developer of next-generation synthetic binders for the life sciences industry announced £190k of new fee-for-service orders and £80k of cash licensing receipts, demonstrating sustained commercial momentum and the commencement of high-margin, recurring revenues from its Optimer platform.</li>
</ul>


The minerals exploration and development Company reports that its proposed joint venture partner, GreenTech Metals Limited, has announced that the Phase 1 drill programme will be accelerated with the addition of a second drill rig at the Munni Munni Platinum-PalladiumCopper-Nickel Project.
GreenTech and Alien are progressing the final administrative processes to enable conclusion of the transaction, and a further announcement will be made in due course.
The developer of next-generation synthetic binders for the life sciences industry announced £190k of new fee-for-service orders and £80k of cash licensing receipts, demonstrating sustained commercial momentum and the commencement of high-margin, recurring revenues from its Optimer platform.


Strategic Minerals PLC - Hybridan Small Cap Feast: 29 January 2026

<ul>
<li>Abingdon Health 6.25p £11.71m (ABDX.L) The international developer, manufacturer and regulatory services provider for rapid diagnostic tests and medtech announces that, further to its announcement yesterday, it has completed and closed the placing to raise gross proceeds of £3.3m.</li>
<li>As part of the Placing, Chris Hand, Executive Chairman of the Company, has agreed to subscribe for £30k.</li>
<li>In addition to the Placing, the Company is providing existing eligible shareholders with the opportunity to subscribe for Retail Offer Shares at the Placing Price, to raise up to £200k. </li>
</ul>


Abingdon Health 6.25p £11.71m (ABDX.L) The international developer, manufacturer and regulatory services provider for rapid diagnostic tests and medtech announces that, further to its announcement yesterday, it has completed and closed the placing to raise gross proceeds of £3.3m.
As part of the Placing, Chris Hand, Executive Chairman of the Company, has agreed to subscribe for £30k.
In addition to the Placing, the Company is providing existing eligible shareholders with the opportunity to subscribe for Retail Offer Shares at the Placing Price, to raise up to £200k. 


Sosandar PLC - Hybridan Small Cap Feast: 14/10/2025

<ul>
<li>1Spatial Holdings 53.0p £60.87m (SPA.L) The global Location Master Data Management software and solutions provider reports Interims to July.</li>
<li>Revenue increased 9% to £17.7m with a 50% increase in SaaS Term licenses to £0.8m and ARR grew 11.9% to £19.1m.</li>
<li>The is EBITDA improved to £2.1m from £2m, while the LBT increased to £0.3m from £0.2m. </li>
</ul>


1Spatial Holdings 53.0p £60.87m (SPA.L) The global Location Master Data Management software and solutions provider reports Interims to July.
Revenue increased 9% to £17.7m with a 50% increase in SaaS Term licenses to £0.8m and ARR grew 11.9% to £19.1m.
The is EBITDA improved to £2.1m from £2m, while the LBT increased to £0.3m from £0.2m. 


United Kingdom

Aptamer Group PLC operates as a biotechnology company. The Company focuses on the development of aptamer technologies and develops nucleic acid aptamers for use in research and development, biomarker discovery, diagnostics, and therapeutic developments. Aptamer Group serves customers in the United Kingdom.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Aptamer Group (APTA LN)

Hybridan Small Cap Feast: 11 February 2026

These are being used as an enabling technology for stability at room temperature, the specialised TrueAmp polymerase maximises coverage across...

Hybridan

PISCES – Shooting the Lights Out or Shooting Ourselves in the Foot?

It will kick off with a five-year stint in the “FCA sandbox” which allows the Government to modify the platform or disapply certain parts of the...

Hybridan

Strategic Minerals PLC - Hybridan Small Cap Feast: 29 January 2026

GreenTech and Alien are progressing the final administrative processes to enable conclusion of the transaction, and a further announcement will be...

Hybridan

Sosandar PLC - Hybridan Small Cap Feast: 14/10/2025

In addition to the Placing, the Company is providing existing eligible shareholders with the opportunity to subscribe for Retail Offer Shares at...

Hybridan

Hybridan Small Cap Feast: 13/10/2025

1Spatial Holdings 53.0p £60.87m (SPA.L) The global Location Master Data Management software and solutions provider reports Interims to July.

Hybridan

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)